MET and central nervous system cancer: These results demonstrated that BIP-MPC-NP potentiated the TMZ-induced restriction on TMZ-resistant glioma xenografts by attenuating DNA damage repair via mitigation of the EGFR and MET signaling pathways (Fig. 7).